Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1815 | 2404 | 32.3 | 73% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
338 | 17249 | GASTROESOPHAGEAL REFLUX DISEASE//GASTROESOPHAGEAL REFLUX//ACHALASIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OMEPRAZOLE | Author keyword | 58 | 18% | 12% | 286 |
2 | LANSOPRAZOLE | Author keyword | 55 | 30% | 6% | 156 |
3 | PANTOPRAZOLE | Author keyword | 53 | 34% | 5% | 126 |
4 | RABEPRAZOLE | Author keyword | 33 | 32% | 3% | 84 |
5 | PROTON PUMP INHIBITOR | Author keyword | 30 | 17% | 7% | 159 |
6 | INTRAGASTRIC PH | Author keyword | 20 | 44% | 1% | 35 |
7 | OKLAHOMA FDN DIGEST | Address | 20 | 54% | 1% | 25 |
8 | ESOMEPRAZOLE | Author keyword | 17 | 26% | 2% | 58 |
9 | PROTON PUMP INHIBITORS | Author keyword | 16 | 11% | 6% | 134 |
10 | H K ATPASE INHIBITOR | Author keyword | 16 | 65% | 1% | 15 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OMEPRAZOLE | 58 | 18% | 12% | 286 | Search OMEPRAZOLE | Search OMEPRAZOLE |
2 | LANSOPRAZOLE | 55 | 30% | 6% | 156 | Search LANSOPRAZOLE | Search LANSOPRAZOLE |
3 | PANTOPRAZOLE | 53 | 34% | 5% | 126 | Search PANTOPRAZOLE | Search PANTOPRAZOLE |
4 | RABEPRAZOLE | 33 | 32% | 3% | 84 | Search RABEPRAZOLE | Search RABEPRAZOLE |
5 | PROTON PUMP INHIBITOR | 30 | 17% | 7% | 159 | Search PROTON+PUMP+INHIBITOR | Search PROTON+PUMP+INHIBITOR |
6 | INTRAGASTRIC PH | 20 | 44% | 1% | 35 | Search INTRAGASTRIC+PH | Search INTRAGASTRIC+PH |
7 | ESOMEPRAZOLE | 17 | 26% | 2% | 58 | Search ESOMEPRAZOLE | Search ESOMEPRAZOLE |
8 | PROTON PUMP INHIBITORS | 16 | 11% | 6% | 134 | Search PROTON+PUMP+INHIBITORS | Search PROTON+PUMP+INHIBITORS |
9 | H K ATPASE INHIBITOR | 16 | 65% | 1% | 15 | Search H+K+ATPASE+INHIBITOR | Search H+K+ATPASE+INHIBITOR |
10 | ILAPRAZOLE | 15 | 67% | 1% | 14 | Search ILAPRAZOLE | Search ILAPRAZOLE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OMEPRAZOLE | 121 | 15% | 30% | 731 |
2 | LANSOPRAZOLE | 89 | 28% | 11% | 267 |
3 | 1023 SK AND F 96022 | 83 | 94% | 1% | 30 |
4 | OMEPRAZOLE 20 MG | 64 | 86% | 1% | 32 |
5 | INTRAGASTRIC PH | 55 | 31% | 6% | 150 |
6 | EROSIVE ESOPHAGITIS | 51 | 28% | 6% | 154 |
7 | RANITIDINE | 50 | 15% | 12% | 300 |
8 | PROTON PUMP INHIBITORS | 49 | 14% | 14% | 325 |
9 | PANTOPRAZOLE | 48 | 32% | 5% | 127 |
10 | HIGH DOSE RANITIDINE | 44 | 77% | 1% | 30 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update | 2014 | 11 | 114 | 54% |
Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors | 2013 | 18 | 56 | 70% |
Proton pump inhibitors: an update of their clinical use and pharmacokinetics | 2008 | 127 | 184 | 45% |
Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH | 2009 | 40 | 88 | 89% |
Review article: cytochrome P450 and the metabolism of proton pump inhibitors - emphasis on rabeprazole | 1999 | 240 | 42 | 52% |
Stereoselective disposition of proton pump inhibitors | 2008 | 37 | 41 | 95% |
Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors | 2000 | 158 | 82 | 88% |
Pharmacokinetic drug interaction profiles of proton pump inhibitors | 2006 | 80 | 107 | 63% |
Medical treatments in the short term management of reflux oesophagitis (Review) | 2007 | 44 | 134 | 87% |
Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem | 2006 | 68 | 20 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OKLAHOMA FDN DIGEST | 20 | 54% | 1.0% | 25 |
2 | HAMMERSMITH INT | 5 | 60% | 0.2% | 6 |
3 | CHEM MFG CONTROLS | 4 | 67% | 0.2% | 4 |
4 | MED GRP 2 | 4 | 75% | 0.1% | 3 |
5 | GERIATR HLTH SCI | 3 | 43% | 0.2% | 6 |
6 | CURE CLIN | 3 | 100% | 0.1% | 3 |
7 | CURE UCLA DIGEST DIS | 2 | 67% | 0.1% | 2 |
8 | ESOPHAGEAL DISORDERS PROGRAM | 2 | 67% | 0.1% | 2 |
9 | KLIN FOR HAMBURG | 2 | 67% | 0.1% | 2 |
10 | KAZUSA S | 2 | 43% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000272413 | RABEPRAZOLE SODIUM//OMEPRAZOLE SULFONE//PANTOPRAZOLE SODIUM |
2 | 0.0000220244 | NON EROSIVE REFLUX DISEASE//GASTROESOPHAGEAL REFLUX DISEASE//HEARTBURN |
3 | 0.0000134021 | AJMALINE//NC 1300 B//CGMP PDE |
4 | 0.0000126088 | SUCRALFATE//PEPTIC ULCER THERAPY//DE NOL |
5 | 0.0000106303 | STRESS ULCER PROPHYLAXIS//STRESS ULCER//STRESS ULCERATION |
6 | 0.0000096806 | GASTRIC METAPLASIA//DUODENAL GASTRIC METAPLASIA//PARIETAL INDEX |
7 | 0.0000081804 | CISAPRIDE//KW 5092//CINITAPRIDE |
8 | 0.0000078008 | ENTEROCHROMAFFIN LIKE CELLS//ECL CELL//ENTEROCHROMAFFIN LIKE CELL |
9 | 0.0000077773 | PARIETAL CELL//SPASMOLYTIC POLYPEPTIDE EXPRESSING METAPLASIA//NASHVILLE VA MED |
10 | 0.0000073015 | HELICOBACTER PYLORI//QUADRUPLE THERAPY//CLARITHROMYCIN RESISTANCE |